prognostic indicators

Research in Review

Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis

07/12/2017

JCP Editors

Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Continued Nivolumab After Progression May Improve Outcomes in Melanoma

07/03/2017

JCP Editors

Patients with advanced melanoma who are treated with nivolumab after their first disease progression may experience tumor response without compromising safety, according to an original investigation published in JAMA...

...

07/03/2017

Journal of Clinical Pathways

Research in Review

Blood Flow Measurement Predicts Effectiveness of Ovarian Cancer Treatment

07/03/2017

JCP Editors

A tool for measuring blood flow and volume to ovarian cancer tumors accurately predicts the effectiveness of treatment, according to a recent study published in Clinical Cancer Research (June 2017;...

A tool...

07/03/2017

Journal of Clinical Pathways

Research in Review

Does Delayed Lymph Node Biopsy Affect Survival Rates in Melanoma?

06/29/2017

JCP Editors

Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...

Recent...

06/29/2017

Journal of Clinical Pathways

Research in Review

RA Relapse Prediction Tool Decreases Cost of Treatment

06/19/2017

JCP Editors

Researchers developed a method of identifying candidates with rheumatoid arthritis (RA) for dose reduction of disease modifying anti-rheumatic drugs (DMARDs). ----- Related Content Certolizumab combo helps curb RA...

...

06/19/2017

Journal of Clinical Pathways

Research in Review

Can Active Surveillance Benefit Younger Patients With Prostate Cancer?

06/19/2017

JCP Editors

Research suggests that age can impact the risk of disease progression in low-risk prostate cancer managed with active surveillance, published in the Journal of Clinical Oncology (June 2017;35[17]:1898-1904). Recent...

...

06/19/2017

Journal of Clinical Pathways

Research in Review

Standard of Care Shift in ALK-Positive Lung Cancer

06/12/2017

JCP Editors

A second-generation inhibitor delays anaplastic lymphoma kinase (ALK)-positive lung cancer growth for a median of 15 months longer and causes fewer adverse events than the current standard of care, according to a new...

A...

06/12/2017

Journal of Clinical Pathways

Research in Review

Targeted Therapy May Improve Outcomes for Patients With Multiple Myeloma

05/22/2017

JCP Editors

Targeted therapy against a particular protein has the potential to improve outcomes and fracture-free survival for patients with multiple myeloma, according to research that will be presented at the 2017 ASCO...

...

05/22/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Subtypes Respond Differently to Androgen Deprivation Therapy

05/17/2017

JCP Editors

Luminal and basal subtyping of prostate cancer may provide a clinical tool for predicting which patients will benefit from androgen deprivation therapy (ADT) after prostatectomy, according to a report published in...

...

05/17/2017

Journal of Clinical Pathways

Research in Review

PD-1 Expression in T Cells Aids Immunotherapy Strategies for NSCLC

05/12/2017

JCP Editors

Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to antitumor response for patients with non-small cell lung cancer (NSCLC), according to research published...

Early...

05/12/2017

Journal of Clinical Pathways